Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

491 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adoption of Expansion Margins to Reduce the Dose Received by the Coronary Arteries and the Risk of Cardiovascular Events in Lymphoma Patients.
De Luca V, Gallio E, Bartoncini S, Giglioli FR, Sardo A, Cavallin C, Iorio GC, Orlandi E, Parise R, Palladino C, Buonavita A, Fiandra C, Levis M, Ricardi U. De Luca V, et al. Among authors: orlandi e. Pract Radiat Oncol. 2021 Jan-Feb;11(1):66-73. doi: 10.1016/j.prro.2020.06.005. Epub 2020 Jun 19. Pract Radiat Oncol. 2021. PMID: 32565414
Efficacy of low-dose radiotherapy (2 Gy × 2) in the treatment of marginal zone and mucosa-associated lymphoid tissue lymphomas.
Cerrato M, Orlandi E, Vella A, Bartoncini S, Iorio GC, Bongiovanni D, Capriotti F, Boccomini C, Vassallo F, Cavallin C, De Luca V, Giglioli FR, Ricardi U, Levis M. Cerrato M, et al. Among authors: orlandi e. Br J Radiol. 2021 Jul 1;94(1123):20210012. doi: 10.1259/bjr.20210012. Epub 2021 Jun 16. Br J Radiol. 2021. PMID: 34111959 Free PMC article.
What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis.
Bonomo P, Merlotti A, Olmetto E, Bianchi A, Desideri I, Bacigalupo A, Franco P, Franzese C, Orlandi E, Livi L, Caini S. Bonomo P, et al. Among authors: orlandi e. Eur J Nucl Med Mol Imaging. 2018 Nov;45(12):2122-2138. doi: 10.1007/s00259-018-4065-5. Epub 2018 Jun 9. Eur J Nucl Med Mol Imaging. 2018. PMID: 29948105 Free PMC article. Review.
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy.
Jereczek-Fossa BA, Palazzi MF, Soatti CP, Cazzaniga LF, Ivaldi GB, Pepa M, Amadori M, Antognoni P, Arcangeli S, Buffoli A, Beltramo G, Berlinghieri S, Bignardi M, Bracelli S, Bruschieri L, Castiglioni S, Catalano G, Di Muzio N, Fallai C, Fariselli L, Filippi AR, Gramaglia A, Italia C, Lombardi F, Magrini SM, Nava S, Orlandi E, Pasinetti N, Sbicego EL, Scandolaro L, Scorsetti M, Stiglich F, Tonoli S, Tortini R, Valdagni R, Vavassori V, Marvaso G; CODRAL (Board of Directors of Radiation Oncology Departments in Lombardy) network. Jereczek-Fossa BA, et al. Among authors: orlandi e. Clin Oncol (R Coll Radiol). 2020 Jul;32(7):e160-e161. doi: 10.1016/j.clon.2020.04.007. Epub 2020 Apr 23. Clin Oncol (R Coll Radiol). 2020. PMID: 32354669 Free PMC article. No abstract available.
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer.
Barcellini A, Murata K, Fontana G, Vai A, Cassani C, Landoni F, Locati LD, Raspagliesi F, Secondino S, Pecorilla M, Yamada S, Okonogi N, Orlandi E. Barcellini A, et al. Among authors: orlandi e. Clin Transl Radiat Oncol. 2024 Apr 20;47:100781. doi: 10.1016/j.ctro.2024.100781. eCollection 2024 Jul. Clin Transl Radiat Oncol. 2024. PMID: 38726346 Free PMC article.
491 results